Enhanced IL-15-mediated NK cell activation and proliferation by an ADAM17 function-blocking antibody involves CD16A, CD137, and accessory cellsJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62024-07-240OAAI
ENHANCING NK CELL FUNCTION IN THE `COLD' TUMOR MICROENVIRONMENT OF PROSTATE CANCER WITH A NOVEL TRI-SPECIFIC KILLER ENGAGER AGAINST PROSTATE-SPECIFIC MEMBRANE ANTIGEN (PSMA)JOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62022-11-070OA
HYPOXIA REPROGRAMS NATURAL KILLER CELLS AND IMPAIRS THEIR THERAPEUTIC POTENTIALJOURNAL FOR IMMUNOTHERAPY OF CANCERIF10.62021-11-100OA